Use of titanium dioxide in medicinal products

9. Februar 2022 – In October 2021, the EU Member States approved the proposal of the European Commission to ban titanium dioxide in all food products in the EU. This ban is expected to come into force in the EU in early 2022 with a transitional period of six months. In contrast to the rule on food products, titanium dioxide is still permitted as an excipient in medicinal products, yet the European Commission intends to re-evaluate the situation in three years’ time.

Swissmedic will closely follow the international evaluations and reassess the situation on an ongoing basis. Until further notice, the pharmaceutical excipient titanium dioxide remains permissible in Switzerland.

For more information, see here.